New Funding Awards May 2022

Friday, June 3, 2022

Sponsored Research

Vivian Chu of Infectious Diseases has received a sub-award through the Atrium Health for a project entitled "Randomized Trial of Non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis (R01 Sub)." Total funding will be $13,571.

Mitchell Horwitz of Cell Therapy has received a sub-award through the National Marrow Donor Program for a project entitled "A Phase 3, Randomized, Open-Label, Multicenter Study, to Compare T-Guard to Ruxolitinib for the Treatment of Patients with Grade III or IV Steroid-Refractory Acute Graft-Versus-Host Disease BMT CTN Protocol #2002." Total funding will be $101,416.

William Jones of Cardiology has received a sub-award () through the Brigham and Women's Hospital for a project entitled "(PRECIDENTD (PREvention of Cardiovascular and DiabEtic kidNey disease in Type 2 Diabetes)." Total funding will be $143,076.

Ravi Karra of Cardiology has received an award from the Ann Theodore Foundation for a project entitled "Epithelioid Mechanisms of Sarcoidosis." Total funding will be $575,000.

Thomas Leblanc of Cell Therapy has received a sub-award (PLACER-2020C3-21247) through the Massachusetts General Hospital for a project entitled "Specialty versus Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia (SCOPE-Leukemia): Comparative Effectiveness Trial." Total funding will be $120,576.

Thomas Leblanc of Cell Therapy has received a sub-award (PLACER-2020C3-21247) through the Massachusetts General Hospital for a project entitled "Specialty versus Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia." Total funding will be $1.

Patricia Lugar of Pulmonary has received a sub-award through the Cincinnati Children's Hospital Medical Center for a project entitled "Clinical Trial Subcontract - Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD)." Total funding will be $27,326.

Jatin Roper of Gastroenterology has received an award from the National Institutes of Health for a project entitled "Wnt signaling in obesity-associated colorectal cancer." Total funding will be $1,841,440.

Rebecca Sadun of Rheumatology has received an award from the Rheumatology Research Foundation for a project entitled "Immunogenicity and risk of autoimmune cross-reactivity of COVID-19 mRNA vaccines in SLE - RRF Investigator Award." Total funding will be $124,994.

Laurie Snyder of Pulmonary has received an award from the University of New Hampshire for a project entitled "CF LTT RDN Expansion Mini Grant Funding." Total funding will be $6,384.

Gayani Tillekeratne of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "Host response-based diagnostics for identifying bacterial versus viral causes of lower respiratory infection in resource-limited settings." Total funding will be $444,617.

James Wharam of General Internal Medicine has received a sub-award (RSGI-20-030-01 - CPP) through the Harvard Pilgrim Health Care, Inc. for a project entitled "Oral Targeted Anticancer Medication Trends and Modifiable Use Predictors (OTAM)." Total funding will be $4,651.

Ian Williamson of Gastroenterology has received an award from the National Institutes of Health for a project entitled “Quantifying Enteric Metabolism of Branched-chain Amino Acids in Relation to Other Dietary and Microbiota Nutrients.” Total funding will be $181,500.

William Yancy of General Internal Medicine has received a sub-award (1R01-DK125792-01A1) through the University of Michigan for a project entitled "Carbohydrate reduction for prevention of type 2 diabetes." Total funding will be $56,485.

 

Industry-sponsored Clinical Trials

James Abbruzzese of Oncology has received an award from Amgen, Inc. for a project entitled "A phase 1/1b/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors." Total funding will be $566,358.

Melissa Daubert of Cardiology has received an award from LEXEO Therapeutics, Inc for a project entitled "Cardiomyopathy associated with Friedreich�s Ataxia." Total funding will be $675,743.

Mitchell Horwitz of Cell Therapy has received a sub-award () through Xenikos BV for a project entitled "BMT CTN 2002 CSPR." Total funding will be $20,283.

Jingquan Jia of Oncology has received an award from Genentech, Inc. for a project entitled "A Phase II Randomized Study of Atezolizumab plus Multi-Kinase Inhibitor versus Multi-Kinase Inhibitor Alone in Subjects with Unresectable, Advanced Hepatocellular Carcinoma Who Previously Received Atezolizumab Plus Bevacizumab (ACCRU-2008)." Total funding will be $1

Thomas Leblanc of Cell Therapy has received an award from Bristol-Myers Squibb Company for a project entitled "Characterizing association between early endpoints and overall survival and event-free survival in resectable non-small cell lung cancer (NSCLS) patients treated with neoadjuvant therapy: A retrospective patient chart study." Total funding will be $43,298.

Andrew Nixon of Oncology has received an award from Genentech, Inc. for a project entitled "Microsatellite Stable, Stage III Colorectal Cancer." Total funding will be $171,383.79,260.

Neha Pagidipati of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "ASCVD EHR Cohort - CardioHealth Alliance Project." Total funding will be $474,990.

Sean Pokorney of Cardiology has received an award from Bayer Healthcare Pharmaceuticals Inc for a project entitled "M2PAM Remote HF ACL Scope." Total funding will be $434,995.

Richard Riedel of Oncology has received an award from Cogent Biosciences, Inc for a project entitled "PEAK." Total funding will be $512,377.

Richard Riedel of Oncology has received an award from Inhibrx, Inc for a project entitled "A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma." Total funding will be $236,374.

Nirmish Shah of Hematology has received an award from AkiraBio, Inc for a project entitled "AKIRA Bio study." Total funding will be $717,887.